Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability

FEBS Journal

Volumn 281, Issue 3, 2014, Pages 802-813

  Yang, Feng ^a   Xue, Xuchao ^b   Zheng, Luming ^b   Bi, Jianwei ^b   Zhou, Yuhong ^b   Zhi, Kangkang ^b   Gu, Yan ^a   Fang, Guoen ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

C Myc; Gastric carcinoma; Insulin like growth factor 2 mRNA binding protein 1; Long noncoding RNA; Proliferation

Indexed keywords

GASTRIC CARCINOMA HIGH EXPRESSED TRANSCRIPT 1; INSULIN LIKE GROWTH FACTOR 2 BINDING PROTEIN 1; LONG UNTRANSLATED RNA; MESSENGER RNA; MYC PROTEIN; SOMATOMEDIN BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; RNA STABILITY; STOMACH CARCINOMA; UPREGULATION;

C-MYC; GASTRIC CARCINOMA; INSULIN-LIKE GROWTH FACTOR 2 MRNA BINDING PROTEIN 1; LONG NON-CODING RNA; PROLIFERATION;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA STABILITY; RNA, LONG NONCODING; RNA, MESSENGER; RNA-BINDING PROTEINS; STOMACH; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84897030519     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12625     Document Type: Article

References (32)

1. Shah MA & Kelsen DP (2010) Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. J Natl Compr Canc Netw 8, 437-447.
2. Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA & Wong R (2011) Guidelines for the management of oesophageal and gastric cancer. Gut 60, 1449-1472.
3. Saka M, Morita S, Fukagawa T & Katai H (2011) Present and future status of gastric cancer surgery. Jpn J Clin Oncol 41, 307-313.
4. Tan HT, Low J, Lim SG & Chung MC (2009) Serum autoantibodies as biomarkers for early cancer detection. FEBS J 276, 6880-6904.
5. Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J & Sung JJ (2010) MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 29, 5761-5771.
6. Resende C, Thiel A, Machado JC & Ristimaki A (2011) Gastric cancer: basic aspects. Helicobacter 16 (Suppl. 1), 38-44.
7. Nishimura Y, Komatsu S, Ichikawa D, Nagata H, Hirajima S, Takeshita H, Kawaguchi T, Arita T, Konishi H, Kashimoto K et al. (2013) Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma. Br J Cancer 108, 1324-1331.
8. Nobili S, Bruno L, Landini I, Napoli C, Bechi P, Tonelli F, Rubio CA, Mini E & Nesi G (2011) Genomic and genetic alterations influence the progression of gastric cancer. World J Gastroenterol 17, 290-299.
9. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C & Snyder M (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74.
10. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG et al. (2012) The GENCODE v7 catalog of human long non-coding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22, 1775-1789.
11. Wilusz JE, Sunwoo H & Spector DL (2009) Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 23, 1494-1504.
12. Pickard MR, Mourtada-Maarabouni M & Williams GT (2013) Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim Biophys Acta 1832, 1613-1623.
13. Ponting CP, Oliver PL & Reik W (2009) Evolution and functions of long non-coding RNAs. Cell 136, 629-641.
14. Cheetham SW, Gruhl F, Mattick JS & Dinger ME (2013) Long non-coding RNAs and the genetics of cancer. Br J Cancer 108, 2419-2425.
15. Prensner JR & Chinnaiyan AM (2011) The emergence of lnc RNAs in cancer biology. Cancer Discov 1, 391-407.
16. Gibb EA, Brown CJ & Lam WL (2011) The functional role of long non-coding RNA in human carcinomas. Mol Cancer 10, 38.
17. Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y & Fang G (2013) Long non-coding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol 139, 437-445.
18. Wierstra I & Alves J (2006) FOXM1c transactivates the human c-myc promoter directly via the two TATA boxes P1 and P2. FEBS J 273, 4645-4667.
19. Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC & Li F (2006) The c-Myc target gene network. Semin Cancer Biol 16, 253-264.
20. Calcagno DQ, Leal MF, Assumpcao PP, Smith MA & Burbano RR (2008) MYC and gastric adenocarcinoma carcinogenesis. World J Gastroenterol 14, 5962-5968.
21. Zhang L, Hou Y, Ashktorab H, Gao L, Xu Y, Wu K & Zhai J (2010) The impact of C-MYC gene expression on gastric cancer cell. Mol Cell Biochem 344, 125-135.
22. Weidensdorfer D, Stohr N, Baude A, Lederer M, Kohn M, Schierhorn A, Buchmeier S, Wahle E & Huttelmaier S (2009) Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. RNA 15, 104-115.
23. Lemm I & Ross J (2002) Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant. Mol Cell Biol 22, 3959-3969.
24. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL et al. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076.
25. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M et al. (2010) A large intergenic non-coding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409-419.
26. Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L et al. (2011) linc RNAs act in the circuitry controlling pluripotency and differentiation. Nature 477, 295-300.
27. Stohr N & Huttelmaier S (2012) IGF2BP1: a posttranscriptional 'driver' of tumor cell migration. Cell Adh Migr 6, 312-318.
28. Zirkel A, Lederer M, Stohr N, Pazaitis N & Huttelmaier S (2013) IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG). Nucleic Acids Res 41, 6618-6636.
29. Hammerle M, Gutschner T, Uckelmann H, Ozgur S, Fiskin E, Gross M, Skawran B, Geffers R, Longerich T, Breuhahn K et al. (2013) Post-transcriptional destabilization of the liver-specific long non-coding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1). Hepatology 58, 1703-1712.
30. Stohr N, Kohn M, Lederer M, Glass M, Reinke C, Singer RH & Huttelmaier S (2012) IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling. Genes Dev 26, 176-189.
31. Manieri NA, Drylewicz MR, Miyoshi H & Stappenbeck TS (2012) Igf2 bp1 is required for full induction of Ptgs2 mRNA in colonic mesenchymal stem cells in mice. Gastroenterology 143, 110-121.
32. Zhao J, Liang Q, Cheung KF, Kang W, Dong Y, Lung RW, Tong JH, To KF, Sung JJ & Yu J (2013) Somatostatin Receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer. Br J Cancer 108, 2557-2564.